A new, optimised diphosphine chemical platform for kit-based, receptor-targeted 99mTc and 188Re radiopharmaceuticals

Rachel E. Nuttall(St Thomas' Hospital), Michelle Ma(St Thomas' Hospital), Jane Sosabowski(Queen Mary University of London), Zilin Yu(Jiangxi University of Traditional Chinese Medicine), Oliver W. L. Carter(St Thomas' Hospital), Ingebjorg Hungnes(King's College London), Alex Rigby(St Thomas' Hospital), Julie Cleaver(Queen Mary University of London), Truc Le-Buu Pham(King's College London), Paul G. Pringle(University of Bristol), Natasha Patel(St Thomas' Hospital), Jennifer L. Young(University of Virginia Health System)
Nuclear Medicine and Biology
November 1, 2025
Cited by 0


Related Papers